Exploring Non-Invasive Brain Stimulation Techniques for Alzheimer’s Disease: Advances and Efficacy

Abstract

Non-invasive brain stimulation (NIBS) is gaining attention as a treatment for cognitive and functional impairment in neurodegenerative disorders, especially Alzheimer’s Disease (AD). This review summarizes the current evidence on various NIBS techniques, including repetitive transcranial magnetic stimulation (rTMS), transcranial electric stimulation (tES), sensory stimulation, photobiomodulation (PBM), and transcranial focused ultrasound (tFUS), focusing on their clinical applications and efficacy across different cognitive decline stages.

Introduction

NIBS methods include rTMS and tES (both direct current [tDCS] and alternating current [tACS]). New approaches such as gamma sensory stimulation, PBM, and tFUS are also emerging. rTMS is effective for treating depression and migraines. Its clinical effectiveness for cognitive impairment in AD shows promising but mixed results. NIBS techniques aim to affect specific brain networks associated with cognitive functions. Research is shifting from a region-based approach to a network-based understanding of brain function, which may increase the effectiveness of personalized NIBS treatments.

Stimulation Techniques

Different NIBS techniques have varied mechanisms. rTMS induces strong neural changes and modulates connectivity, while tDCS alters neuronal excitability, and tACS entrains brain oscillations. Sensory stimulation uses time-varying stimuli to synchronize brain activity, particularly gamma oscillations, vital for cognition. PBM employs light to energize cells and has demonstrated potential benefits in reducing AD pathology. tFUS focuses ultrasound energy to stimulate brain regions safely and precisely.

Efficacy of NIBS in Alzheimer’s Disease Dementia

Among NIBS modalities, rTMS has the most extensive evidence, improving global cognition and memory in AD. Common target areas include the dorsolateral prefrontal cortex and the precuneus. Clinical studies report increases in cognitive assessment scores following rTMS treatment. tDCS also shows cognitive benefits but with less effectiveness than rTMS. Studies on other NIBS techniques like tACS and sensory stimulation are limited but suggest potential for improving function and reducing symptoms.

Potential for Mild Cognitive Impairment and Subjective Cognitive Decline

Research on MCI indicates that rTMS and tDCS provide cognitive improvements, particularly in memory and global cognition. Early evidence suggests beneficial effects of sensory stimulation and PBM in this group. tFUS has also shown initial promise in enhancing cognitive function.

Conclusion

NIBS presents a promising option for cognitive enhancement in AD. High-frequency rTMS targeting specific brain areas yields positive cognitive outcomes. tDCS and emerging techniques like tACS and sensory stimulation offer supplementary benefits. Research continues to explore the optimal use and personalization of NIBS protocols to maximize effectiveness for individuals facing cognitive decline. Continued investigation into home-based NIBS options and combined treatments with pharmacological agents may enhance therapeutic outcomes for patients.